Disease/Infection News

RSS

Syntiron grants sanofi pasteur exclusive world-wide license to its human vaccine against MRSA

Syntiron today announced that it has granted sanofi pasteur an exclusive world-wide license to its human vaccine against Staphylococcus aureus. The agreement includes an undisclosed initial licensing fee, milestone payments and royalty payments on future sales of the product. Staphylococcus aureus, or MRSA (pronounced Mer-sa) is an important hospital-acquired infection and is a major cause of illness and death resulting in excess of 18,000 US deaths a year and a half million hospitalizations, creating a significant economic burden of approximately $3.4 billion annually to the American health care system.

16 Dec 2009

More details emerge about UNITAID's plan for patent pool for HIV/AIDS drugs

News outlets continued to follow UNITAID's recent announcement to create a patent pool aimed at lowering the cost of HIV/AIDS drugs for low- and middle-income countries. Though UNITAID's board "voted Monday to create a board to run the new patent pool, and set a target of having five AIDS drugs in the pool by mid-2010," the group "punted on the thorny issue of which countries outside of Africa to include in the pool," Forbes reports.

16 Dec 2009

NanoBio, GSK partner to develop and commercialize novel cold sore treatment compound

GlaxoSmithKline plc and NanoBio Corporation today announced an exclusive licensing agreement in the United States and Canada for the over-the-counter (OTC) use of NB-001, a novel, patented compound representing the next advance in the treatment of cold sores. Developed by NanoBio, NB-001 provides significant antimicrobial activity against the virus that causes cold sores, herpes labialis.

16 Dec 2009

Awareness increase program of HIV/AIDS patients on ADAP waiting lists

In response to the growing number of HIV/AIDS patients on AIDS Drug Assistance Program (ADAP) waiting lists, the National Minority AIDS Council and the Flowers Heritage Foundation have joined forces to increase awareness of Bridge the Gap, a unique program that provides medication for people currently waiting for ADAP enrollment.

16 Dec 2009

BUSM Pulmonary Center awarded $1.4M grant to derive stem cells and lung progenitors from lung disease patients

Boston University School of Medicine's (BUSM) Pulmonary Center has received a two-year $1.4 million grant from the National Heart, Lung, and Blood Institute to derive stem cells and lung progenitors from patients with lung disease.

16 Dec 2009

Walgreens offers H1N1 vaccine in 27 states

Walgreens, the nation’s largest drugstore chain and an industry leader with more than 17,000 certified or licensed immunizers, today announced it is offering H1N1 vaccine at more than 1,500 Walgreens pharmacies and select Take Care Clinics in 27 states, as well as the District of Columbia.

16 Dec 2009

Pomegranate rind, metal salts and Vitamin C: An effective combination for treating MRSA infection

Pomegranates have already been hailed as a super-food but a team of scientists from Kingston University in South West London has found a new use for the deep red fruit. The team, led by Professor Declan Naughton, has discovered that the rind can be turned into an ointment for treating MRSA and other common hospital infections.

16 Dec 2009

HHS to provide H1N1 response update on December 17, 2009

U.S. Department of Health and Human Services (HHS) Secretary Kathleen Sebelius and senior HHS officials leading the H1N1 response at the Department will hold a press conference, at the National Press Club on Thursday, December 17, 2009.

16 Dec 2009

DNA reveals earliest proven case of leprosy, Turin Shroud not from Jesus-era Jerusalem

The DNA of a 1st century shrouded man found in a tomb on the edge of the Old City of Jerusalem has revealed the earliest proven case of leprosy. Details of the research will be published December 16 in the PloS ONE Journal.

16 Dec 2009

H1N1 outbreak reveals existing gaps in nation's public health emergency preparedness

The seventh annual Ready or Not? Protecting the Public's Health from Diseases, Disasters, and Bioterrorism report, released today by the Trust for America's Health (TFAH) and the Robert Wood Johnson Foundation (RWJF), found that the H1N1 flu outbreak has exposed serious underlying gaps in the nation's ability to respond to public health emergencies and that the economic crisis is straining an already fragile public health system.

16 Dec 2009

MRSA, the most concerning pathogen to surveyed for skin and skin structure infections

Arlington Medical Resources (AMR) and Decision Resources find that methicillin-resistant Staphylococcus aureus (MRSA) is the most concerning pathogen to surveyed European infectious disease specialists with regard to their treatment of skin and skin structure infections.

16 Dec 2009

Human Rhodesian sleeping sickness in Uganda points to infected livestock movements

The northwards spread of human Rhodesian sleeping sickness in Uganda is likely due to the movement of infected livestock, according to new findings from an interdisciplinary research group including members from the Centre for Infectious Diseases, University of Edinburgh; the Ministry of Health, Uganda; and the Universities of Oxford and Southampton.

16 Dec 2009

Pennsylvania expands H1N1 vaccination program to everyone

Certified healthcare providers who have already immunized patients most at risk of complications from the H1N1 flu virus may now offer the vaccine to anyone who wants it, the Department of Health announced today.

16 Dec 2009

Immune system produces neutralizing antibodies capable of blocking HIV, says study

Scientists seeking to understand how to make an AIDS vaccine have found the cause of a major roadblock. It turns out that the immune system can indeed produce cells with the potential to manufacture powerful HIV-blocking antibodies - but at the same time, the immune system works equally hard to make sure these cells are eliminated before they have a chance to mature.

16 Dec 2009

Physicians need to utilize best practices to treat HAE patients in emergency settings

Hereditary Angioedema (HAE) is an autosomal dominant disease causing acute attacks of intense edema. These attacks can result in life-threatening complications, including asphyxiation.

16 Dec 2009

Chagas disease transmission in Peru linked to migration and urbanization patterns

New research shows how the migration and settlement patterns associated with the rapid urbanization of Peru may link to Chagas disease transmission. The

16 Dec 2009

Post-surgical infections raise healthcare expenditures

Post-surgical infections significantly increase the chance of hospital readmission and death and cost as much as $60,000 per patient, according to Duke University Medical Center researchers who conducted the largest study of its kind to date.

16 Dec 2009

Infectious virus particles can bind to the surface of red blood cells: MHRP researchers

Free infectious HIV-1 is widely thought to be the major form of the virus in the blood of infected persons. U.S. Military HIV Research Program (MHRP) researchers, however, have demonstrated that essentially all of the infectious virus particles can bind to the surface of red blood cells isolated from each of 30 normal (non-infected) human donors.

16 Dec 2009

Drug monitoring may provide alternative treatments for patients with severe H1N1

An international team of Canadian and Spanish scientists have found the first potential immunological clue of why some people develop severe pneumonia when infected by the pandemic H1N1 virus.

16 Dec 2009

Interactive education program to fight against malaria

ONE and Malaria No More announced today they are accepting applications for the first-ever "Malaria Griots" program, a dynamic education course that will train and educate participants to become leaders in the fight against malaria.

16 Dec 2009

Disease/Infection News

Syntiron grants sanofi pasteur exclusive world-wide license to its human vaccine against MRSA

More details emerge about UNITAID's plan for patent pool for HIV/AIDS drugs

NanoBio, GSK partner to develop and commercialize novel cold sore treatment compound

Awareness increase program of HIV/AIDS patients on ADAP waiting lists

BUSM Pulmonary Center awarded $1.4M grant to derive stem cells and lung progenitors from lung disease patients

Walgreens offers H1N1 vaccine in 27 states

Pomegranate rind, metal salts and Vitamin C: An effective combination for treating MRSA infection

HHS to provide H1N1 response update on December 17, 2009

DNA reveals earliest proven case of leprosy, Turin Shroud not from Jesus-era Jerusalem

H1N1 outbreak reveals existing gaps in nation's public health emergency preparedness

MRSA, the most concerning pathogen to surveyed for skin and skin structure infections

Human Rhodesian sleeping sickness in Uganda points to infected livestock movements

Pennsylvania expands H1N1 vaccination program to everyone

Immune system produces neutralizing antibodies capable of blocking HIV, says study

Physicians need to utilize best practices to treat HAE patients in emergency settings

Chagas disease transmission in Peru linked to migration and urbanization patterns

Post-surgical infections raise healthcare expenditures

Infectious virus particles can bind to the surface of red blood cells: MHRP researchers

Drug monitoring may provide alternative treatments for patients with severe H1N1

Interactive education program to fight against malaria

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News